High blood pressure (BP), the most common primary care diagnosis in the United States, affects more than 31% of adults
1 and is a major risk factor for the development of cardiovascular and renal diseases.
2-4 Even elevated levels of BP below clinical treatment thresholds are associated with increased subclinical atherosclerosis, target-organ damage, and cardiovascular morbidity and mortality compared with ideal BP.
5,6 Increases in BP have been documented in childhood, with racial/ethnic minorities and young men disproportionately contributing to the total US burden of high BP at younger ages.
1,7-11 Considering that half of the US population develops high BP by age 60 years, characterizing the ages at which populations transition between BP categories is needed to inform prevention and management efforts.
12